Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · 27 Feb 2021Exact title match Conference abstract · 2018 The story of glatiramer acetate (copaxone) in the treatment of multiple sclerosis - the potential for neuroprotection by immunomodulatory treatment
Multiple sclerosis (MS) is currently recognized as complex diseases in which inflammatory reactivity in the central nervous system (CNS) results in demyelination, axonal and neuronal pathology. Treatment strategies thus…
Conference abstract · 2017 Multiple sclerosis, corpus callosum and bedside test
bipedal activities. Affecting CC can disturb synchrony between the two hemispheres. Methodology: Seventy multiple sclerosis patients from outpatient clinics and home visits were tested for bimanual hand function…
Conference abstract · 2019 Dementia is a disease of the ependymal layer: Novel theory from looking at cognitive impairment in multiple sclerosis
intricacies of dementia are explored in relation to varied studies on brain atrophy in multiple sclerosis and used to delineate the primary pathology of the latter. The theory examines ... high frequency of cognitive…
Conference abstract · 2012 Multiple Sclerosis in women: Pregnancy
Multiple Sclerosis (MS) as other well recognized immunologically mediated diseases have a strong female predominance. Endocrine and immunological aspects are relevant where estrogens specifically estriol at a high dose…
Opinion · 1 Jul 2024 Multiple Sclerosis: Insights and Strategies for Managing Multiple Sclerosis
Conference abstract · 22 Feb 2021 Review of neuropsychology use in multiple sclerosis
Multiple Sclerosis (MS) is a disabling neurological disease common in Scotland. Apart from physical disability MS causes fatigue, depression, anxiety, and cognitive decline. Neuropsychology began to be utilised for…
Conference abstract · 30 Aug 2017 Mast cells, the key to multiple sclerosis?
für klinische Medicin. 122, 378 – 380. 2. Krüger, P.G. (2001) Mast cells and multiple sclerosis: a quantitative analysis. Neuropathology and Applied Neurobiology. 27, 275 – 280. 3. Krüger, P.G and Mørk ... Mast cells…
Conference abstract · 2017 Multiple Sclerosis, Corpus Callosum and Bediside Test
speed of clapping (bimanual activity) can reflect the involvement of CC in Multiple Sclerosis. Consecutive 70 Multiple Sclerosis patients from Outpatient clinics and Home visits were tests for bimanual hand
Conference abstract · 29 Aug 2020 Defects of the Mitochondrial Genome in Multiple Sclerosis
impaired mitochondrial function has been implicated in the pathogenicity of multiple sclerosis (MS), a chronic inflammatory, demyelinating, and neurodegenerative disease of the CNS. We investigated whether variants in…
Conference abstract · 2016 Exploring the association between fatigue and autonomic dysfunction in Multiple Sclerosis
Background: Fatigue is a common debilitating symptom of multiple sclerosis (MS) but its pathophysiology remains poorly understood. Recent studies in a variety of diseases have shown dysfunction of the cardiovascular
Conference abstract · 2016 What role does the environment play as risk factor in Multiple Sclerosis?
exact mechanisms underlying neuroinflammation and neuropathology in multiple sclerosis (MS) are still unknown, but susceptibility depends on a combination of genetic and environmental risk factors and their…
Conference abstract · 2016 Novel aspects on the role of potential environmental risk factors in Multiple Sclerosis
exact mechanisms underlying neuroinflammation and neuropathology in multiple sclerosis (MS) are still unknown, but susceptibility depends on a combination of genetic and environmental risk factors and their…
Conference abstract · 23 Sep 2019 Genetic background influences immunity-related genes in two Iranian ethnical multiple sclerosis groups
Multiple Sclerosis (MS) remains a poorly-understood autoimmune disease in the Central Nervous System (CNS) with unknown etiology and pathogenesis. Iranian population consisted of different ethnical groups with a specific
Conference abstract · 27 Aug 2018 The effects of high frequency repetitive Transcranial Magnetic Stimulation in patients with Multiple Sclerosis
transcranial magnetic stimulation (rTMS) applied bilaterally over the primary motor cortex in patients with multiple sclerosis (MS) in clinical settings. We investigated a heterogeneous group of 35 patients with…
Conference abstract · 22 Sep 2016 Beyond Diagnosis: The individualized approaches complementary and alternative medicine practitioners take in working with clients with multiple sclerosis
Sedlacek wrote an article entitled, “Remedial massage in multiple sclerosis,” for the journal, Hippokrates. Since then manual therapists and complementary and alternative medicine practitioners have been assessing…
Conference abstract · 2022 Unmet needs and treatment of relapsing-remitting multiple sclerosis in saudi arabia: focus on the role of ofatumumab
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) may not be receiving optimal treatment. A virtual meeting of ten expert ... RRMS), and the role of…
Conference abstract · 8 Mar 2018 Interleukin 1 receptor antagonist and 2'-5' oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients
Multiple sclerosis (MS) is a multi-factorial disease of the Central Nervous System (CNS) affecting young adults leading to significant disabilities over time. MS is now believed to be prevalent
Conference abstract · 16 Jun 2016 Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis- A population based study from DANBIO and the Danish Multiple Sclerosis Registry
tumor necrosis factor-Ã?± (TNF) as an important factor in the pathogenesis of multiple sclerosis (MS) has emerged. However, attempts of treating MS with TNF-inhibitors (TNFi) have increased disease ... general…
Research article · 11 May 2018 The Patterns of Clinical Presentation of Multiple Sclerosis in Patients admitted to the National Center of Neurological Sciences, Khartoum, Sudan 2018
Background: Multiple sclerosis (MS) is an immunemediated inflammatory disease that attacks myelinated axons in the central nervous system leading to significant disability. Worldwide, approximately 2.1 million peoples…
Conference abstract · 26 Oct 2016 High-resolution diffusion tensor spinal cord MRI measures as biomarkers of disability progression in a rodent model of progressive multiple sclerosis
Standard MRI sequences have been shown to be insensitive and non-specific in monitoring multiple sclerosis (MS) disease progression. This lack of reliability of spinal cord imaging in identifying significant
Research article · 1 Mar 2021 Infection and genotype relationship in multiple sclerosis: Do Chlamydophila pneumoniae and human herpes virus-6 infections together with APO E alleles have a role in the etiopathogenesis of multiple sclerosis?
Despite numerous studies in many laboratories over several years, the etiology of Multiple Sclerosis (MS) is still unknown. It was suggested that some infectious agents play a role
Conference abstract · 2018 Effects of eight-week home-based yoga and resistance training on muscle strength, functional capacity and balance in patients with multiple sclerosis
Muscle weakness, fatigue and balance disturbances contribute to the reduction of daily activity in multiple sclerosis (MS) patients. Therapeutic strategies to promote improvements in muscle strength, functional capacity…
Conference abstract · 2016 Fluvoxamine- An antidepressant drug with anti-inflammatory and oligodendrogenesis effects in rat model of monophasic multiple sclerosis: Studies in vivo and in vitro
Multiple sclerosis (MS) is associated with a neuropsychiatric problem, of which depression is the commonest. Also, antidepressant drugs are known to impact on the immune system and CNS cells
Conference abstract · 18 Jul 2016 T-VDMS- Therapeutic Potential of Vitamin D3 as an add on to Interferon Beta in Patients with Multiple Sclerosis in Sulaimaniyah, KRG-Iraq
Treatment of Multiple Sclerosis (MS) has received substantial attention due to devastating symptoms, disability progression, mental health and cost of polytherapy. To investigate the effect of vitamin D supplementation
Conference abstract · 17 May 2017 Interaction between viruses and the immune system: A pathogenic role for HHV-6A, EBV, and the complement system in multiple sclerosis and age-related macular degeneration; Two hypotheses
lymphocytes and thereby attacking the immune system. A more complicated example is seen in multiple sclerosis (MS) where human herpes virus-6A (HHV-6A) infects astrocytes by docking ... complement system in the eyes of…

